<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-FIMF0000005898001LC</udiDi>
    <basicUdiDi>B-FIMF0000005898001LC</basicUdiDi>
    <tradeName>Abilar®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Repolar Pharmaceuticals Oy</manufacturerName>
    <manufacturerSrn>FI-MF-000000589</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8001</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T23:02:01.124Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-FIMF0000005899010LL</udiDi>
    <basicUdiDi>B-FIMF0000005899010LL</basicUdiDi>
    <tradeName>Abilar® Nail Fungal Treatment</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Repolar Pharmaceuticals Oy</manufacturerName>
    <manufacturerSrn>FI-MF-000000589</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>9010</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T23:02:01.058Z</lastUpdated>
  </row>
</eudamedExport>